Ikko Muto
Yame, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Efficacy and safety of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma in Japan: Results of the Japan Clinical Oncology Group single-arm confirmatory trial (JCOG1605).
Journal: The British journal of dermatology
Published: October 22, 2025
Effectiveness and Prognosis of Systemic Chemotherapy for Unresectable Malignant Apocrine and Eccrine Tumors: A Real-World Multicenter Retrospective Study.
Journal: JCO global oncology
Published: September 12, 2025
An Open-Label, Multicenter, Phase II Study of Bexarotene in Patients with Adult T-Cell Leukemia/Lymphoma.
Journal: The Journal of dermatology
Published: July 12, 2025
Bexarotene-induced hypothyroidism and dyslipidemia; a nation-wide study.
Journal: Endocrine journal
Published: June 05, 2024
Exploring Predictors of Hypertension Development With Pazopanib and Examining Predictive Performance Over Time.
Journal: In vivo (Athens, Greece)
Published: February 20, 2024
Efficacy of Nivolumab and Ipilimumab Combined Therapy as a First-Line Therapy for Patients with Advanced Melanoma and the Urgent Need for an Effective Second-Line Therapy for Patients with Wild-Type BRAF in Japan: A Single Center Retrospective Study.
Journal: The Kurume medical journal
Published: October 04, 2023
Recent treatment and prognosis in 643 patients with extramammary Paget's disease.
Journal: Experimental dermatology
Published: September 05, 2023
Systemic therapy for Asian patients with advanced BRAF V600-mutant melanoma in a real-world setting: A multi-center retrospective study in Japan (B-CHECK-RWD study).
Journal: Cancer medicine
Published: March 31, 2023
Transcription factor activating enhancer-binding protein 2B expression correlates with invasiveness and prognosis of extramammary Paget's disease.
Journal: Pathology, research and practice
Published: September 23, 2022
Safety and efficacy of bexarotene for Japanese patients with cutaneous T-cell lymphoma: Real-world experience from post-marketing surveillance.
Journal: The Journal of dermatology
Published: August 05, 2021
Outcome of combination therapy using BRAF and MEK inhibitors among Asian patients with advanced melanoma: An analysis of 112 cases.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 20, 2020
Last Updated: 09/26/2026